Position in HALO
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$10,768,456
+$1,520,427 QoQ
Shares Held
166,617
+21.3% QoQ
Ownership
0.140%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ASSETMARK, INC holds $266,175,967 across 93 Biotechnology names. HALO ranks #3 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
3,388,920 | $145,350,778 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
59,954 | $26,771,859 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
This page
|
166,617 | $10,768,456 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,316 | $9,515,834 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
29,569 | $8,781,105 | |
| 6 | ARGX |
Argenx SE
|
9,275 | $6,773,068 | |
| 7 | GMAB |
Genmab A/S
|
224,144 | $6,013,783 | |
| 8 | INSM |
INSMED Inc
|
34,258 | $5,601,868 |
All Filings in HALO
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,768,456 | 166,617 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $9,248,029 | 137,415 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $9,009,598 | 122,847 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $6,322,406 | 121,538 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $6,762,009 | 105,971 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $4,913,481 | 102,771 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $5,332,421 | 93,159 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $4,438,766 | 84,774 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,391,324 | 107,948 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,887,896 | 105,192 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,348,765 | 61,486 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $2,811,836 | 77,955 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,439,457 | 37,692 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $1,668,649 | 29,326 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,006,293 | 25,450 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $95,920 | 2,180 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $53,638 | 1,345 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $56,535 | 1,406 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $55,121 | 1,355 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $56,081 | 1,235 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $51,487 | 1,235 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $39,720 | 930 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||